174 related articles for article (PubMed ID: 38197430)
1. Novel two-tiered screening approach identifies synergistic combinations of natural compounds for prostate cancer prevention and treatment.
Friedman CA; Saha A; Lavender Hackman G; Lu X; Lodi A; Tiziani S; DiGiovanni J
Mol Carcinog; 2024 Apr; 63(4):589-600. PubMed ID: 38197430
[TBL] [Abstract][Full Text] [Related]
2. Prostate cancer chemoprevention by silibinin: bench to bedside.
Singh RP; Agarwal R
Mol Carcinog; 2006 Jun; 45(6):436-42. PubMed ID: 16637061
[TBL] [Abstract][Full Text] [Related]
3. Molecular targets for green tea in prostate cancer prevention.
Adhami VM; Ahmad N; Mukhtar H
J Nutr; 2003 Jul; 133(7 Suppl):2417S-2424S. PubMed ID: 12840218
[TBL] [Abstract][Full Text] [Related]
4. Natural Compounds in Prostate Cancer Prevention and Treatment: Mechanisms of Action and Molecular Targets.
Fontana F; Raimondi M; Marzagalli M; Di Domizio A; Limonta P
Cells; 2020 Feb; 9(2):. PubMed ID: 32085497
[TBL] [Abstract][Full Text] [Related]
5. Acetyl-L-Carnitine downregulates invasion (CXCR4/CXCL12, MMP-9) and angiogenesis (VEGF, CXCL8) pathways in prostate cancer cells: rationale for prevention and interception strategies.
Baci D; Bruno A; Cascini C; Gallazzi M; Mortara L; Sessa F; Pelosi G; Albini A; Noonan DM
J Exp Clin Cancer Res; 2019 Nov; 38(1):464. PubMed ID: 31718684
[TBL] [Abstract][Full Text] [Related]
6. Silibinin inhibits hypoxia-induced HIF-1α-mediated signaling, angiogenesis and lipogenesis in prostate cancer cells: In vitro evidence and in vivo functional imaging and metabolomics.
Deep G; Kumar R; Nambiar DK; Jain AK; Ramteke AM; Serkova NJ; Agarwal C; Agarwal R
Mol Carcinog; 2017 Mar; 56(3):833-848. PubMed ID: 27533043
[TBL] [Abstract][Full Text] [Related]
7. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
8. A cancer chemopreventive agent silibinin, targets mitogenic and survival signaling in prostate cancer.
Singh RP; Agarwal R
Mutat Res; 2004 Nov; 555(1-2):21-32. PubMed ID: 15476849
[TBL] [Abstract][Full Text] [Related]
9. GLS-driven glutamine catabolism contributes to prostate cancer radiosensitivity by regulating the redox state, stemness and ATG5-mediated autophagy.
Mukha A; Kahya U; Linge A; Chen O; Löck S; Lukiyanchuk V; Richter S; Alves TC; Peitzsch M; Telychko V; Skvortsov S; Negro G; Aschenbrenner B; Skvortsova II; Mirtschink P; Lohaus F; Hölscher T; Neubauer H; Rivandi M; Labitzky V; Lange T; Franken A; Behrens B; Stoecklein NH; Toma M; Sommer U; Zschaeck S; Rehm M; Eisenhofer G; Schwager C; Abdollahi A; Groeben C; Kunz-Schughart LA; Baretton GB; Baumann M; Krause M; Peitzsch C; Dubrovska A
Theranostics; 2021; 11(16):7844-7868. PubMed ID: 34335968
[TBL] [Abstract][Full Text] [Related]
10. Silibinin prevents prostate cancer cell-mediated differentiation of naïve fibroblasts into cancer-associated fibroblast phenotype by targeting TGF β2.
Ting HJ; Deep G; Jain AK; Cimic A; Sirintrapun J; Romero LM; Cramer SD; Agarwal C; Agarwal R
Mol Carcinog; 2015 Sep; 54(9):730-41. PubMed ID: 24615813
[TBL] [Abstract][Full Text] [Related]
11. The strategies to control prostate cancer by chemoprevention approaches.
Ting H; Deep G; Agarwal C; Agarwal R
Mutat Res; 2014 Feb; 760():1-15. PubMed ID: 24389535
[TBL] [Abstract][Full Text] [Related]
12. Metformin targets c-MYC oncogene to prevent prostate cancer.
Akinyeke T; Matsumura S; Wang X; Wu Y; Schalfer ED; Saxena A; Yan W; Logan SK; Li X
Carcinogenesis; 2013 Dec; 34(12):2823-32. PubMed ID: 24130167
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of action of novel agents for prostate cancer chemoprevention.
Singh RP; Agarwal R
Endocr Relat Cancer; 2006 Sep; 13(3):751-78. PubMed ID: 16954429
[TBL] [Abstract][Full Text] [Related]
14. Combinatorial treatment with natural compounds in prostate cancer inhibits prostate tumor growth and leads to key modulations of cancer cell metabolism.
Lodi A; Saha A; Lu X; Wang B; Sentandreu E; Collins M; Kolonin MG; DiGiovanni J; Tiziani S
NPJ Precis Oncol; 2017; 1():. PubMed ID: 29202102
[TBL] [Abstract][Full Text] [Related]
15. Antiproliferative and apoptotic effects of silibinin in rat prostate cancer cells.
Tyagi A; Bhatia N; Condon MS; Bosland MC; Agarwal C; Agarwal R
Prostate; 2002 Nov; 53(3):211-7. PubMed ID: 12386921
[TBL] [Abstract][Full Text] [Related]
16. α-Mangostin, a xanthone from mangosteen fruit, promotes cell cycle arrest in prostate cancer and decreases xenograft tumor growth.
Johnson JJ; Petiwala SM; Syed DN; Rasmussen JT; Adhami VM; Siddiqui IA; Kohl AM; Mukhtar H
Carcinogenesis; 2012 Feb; 33(2):413-9. PubMed ID: 22159229
[TBL] [Abstract][Full Text] [Related]
17. Prostate cancer prevention by silibinin.
Singh RP; Agarwal R
Curr Cancer Drug Targets; 2004 Feb; 4(1):1-11. PubMed ID: 14965263
[TBL] [Abstract][Full Text] [Related]
18. 6-Shogaol from dried ginger inhibits growth of prostate cancer cells both in vitro and in vivo through inhibition of STAT3 and NF-κB signaling.
Saha A; Blando J; Silver E; Beltran L; Sessler J; DiGiovanni J
Cancer Prev Res (Phila); 2014 Jun; 7(6):627-38. PubMed ID: 24691500
[TBL] [Abstract][Full Text] [Related]
19. Identifying the differential effects of silymarin constituents on cell growth and cell cycle regulatory molecules in human prostate cancer cells.
Deep G; Oberlies NH; Kroll DJ; Agarwal R
Int J Cancer; 2008 Jul; 123(1):41-50. PubMed ID: 18435416
[TBL] [Abstract][Full Text] [Related]
20. Trimethoxy-resveratrol and piceatannol administered orally suppress and inhibit tumor formation and growth in prostate cancer xenografts.
Dias SJ; Li K; Rimando AM; Dhar S; Mizuno CS; Penman AD; Levenson AS
Prostate; 2013 Aug; 73(11):1135-46. PubMed ID: 23657951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]